PK

ProtoKinetix IncOOTC PKTX Stock Report

Last reporting period 30 Sep, 2023

Updated 15 Nov, 2024

Last price

Market cap $B

0.004

Micro

Exchange

OOTC - OTC

PKTX Stock Analysis

PK

Uncovered

ProtoKinetix Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0.004

Dividend yield

Shares outstanding

322.88 B

Protokinetix, Inc. is a research and development stage biotechnology company engaged in the scientific medical research of anti-aging glycoproteins. The company is headquartered in Dalton, Ohio. The company went IPO on 2002-01-07. The firm is focused on the scientific medical research of anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). The Company’s anti-aging glycopeptide is for the ophthalmology, dermatology, transplant support and biomanufacturing. The firm has not developed a commercially viable product and has not generated any revenue

View Section: Eyestock Rating